"Phase 3"
Latest news and video coverage curated from trusted media outlets
0 shares | ShareTweetSavePostSend |
![]() Bigger BluePrints - Working on Phase 3 - Ep16 - First Playthrough since Fluids - #Azeron | !Charity | #satisfactory Credit: RumblePublished | |
![]() [DROPS] Gray Zone Warfare - Flannel Finale Credit: RumblePublished | |
![]() Phase 3! - Satisfactory: Building efficiently Credit: RumblePublished | |
![]() 1.1 update!!!! - Working on Phase 3 - Ep15 - First Playthrough since Fluids - #Azeron | !Charity | #satisfactory Credit: RumblePublished | |
![]() [DROPS] Gray Zone Warfare - Flannel Paradise Credit: RumblePublished | |
![]() Working on Phase 3 - Ep14 - First Playthrough since Fluids - #Azeron | !Charity | #satisfactory Credit: RumblePublished | |
You Might Like
India’s first Dengue vaccine: Phase 3 trial enrollment nears completionFor years now, scientists have tried to develop a safe and effective dengue vaccine. The challenge however, is that there are four different types of dengue viruses, and a common vaccine must protect..IndiaTimes - Published | |
Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta*Business Wire India*Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ovarian..Business Wire India - Published | |
Kashiv BioSciences Announces Positive Topline Results from Confirmatory Efficacy Study of ADL-018, Biosimilar Candidate to XOLAIR® (omalizumab)*Business Wire India* · Positive results from the confirmatory clinical efficacy and safety study of ADL-018, proposed biosimilar to XOLAIR® · The clinical study met its primary endpoint in..Business Wire India - Published | |
Everest Medicines Announces NEFECON® Inclusion in China’s Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)Shanghai, China – May 21, 2025 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and..EQS Group - Published | |
Everest Medicines Announces NMPA Full Approval of NEFECON® for the Treatment of Primary Immunoglobulin A nephropathy (IgAN) in Adults at Risk of Disease ProgressionShanghai, China – May 7, 2025 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and..EQS Group - Published | |
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong KongShanghai, China – April 30, 2025 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and..EQS Group - Published | |
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trialnewKerala.com - Published | |
What is Orforglipron, the pill alternative to OzempicOrforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 diabetes and obesity. Unlike injectable GLP-1s like Ozempic, orforglipron..IndiaTimes - Published | |
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024Shanghai, China — March 26, 2025 — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing..EQS Group - Published | |
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14 EVM14 received U.S. FDA clearance for its IND application, becoming Everest’s first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global..EQS Group - Published | |
MANA Projects Strengthens Presence in Sarjapur Road with New 5.5 Acre Land Acquisition![]() NewsVoir - Published | |
Everest Medicines Presents Complete Maintenance Period Data for Etrasimod at ECCO 2025 Data confirms significant clinical and endoscopic benefits of etrasimod 2mg after 40 weeks of maintenance treatment Etrasimod demonstrates robust efficacy across multiple endpoints,..EQS Group - Published | |
Everest Medicines Announces the Implementation of NEFECON® National Reimbursement Drug List Pricing in China for the Treatment for IgA NephropathyShanghai, China – January 1, 2025 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published | SHOCKING! Director of play school in Noida held after spy camera found in washroom, police says...The director of a play school was arrested in Noida's Phase-3 police station after a spy camera was reportedly detected in the bulb holder of the school's washroom, said the police.DNA - Published |
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China PatientsShanghai, China – December 18, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing..EQS Group - Published | Everest Medicines Announces the Inclusion of VELSIPITY® in the Catalog of Pharmaceutical and Medical Devices Imported from Hong Kong and Macau for the Nine Municipalities in Guangdong Province within the Guangdong-Hong Kong-Macau Greater Bay AreaShanghai, China – December 16, 2024 - Everest Medicines (HKEX 1952.HK,“Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published |
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong KongShanghai, China – December 2, 2024— Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published | Everest Medicines Announces NEFECON®, the World’s First Approved Treatment for IgA Nephropathy, is Included in China’s National Reimbursement Drug ListShanghai, China – November 28, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing..EQS Group - Published |
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA NephropathyShanghai, China – November 19, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing..EQS Group - Published | Advaiya and Crayon Host Customer Roundtable to Explore Cloud Security and Modern Workplace Solutions![]() NewsVoir - Published |
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis PatientsShanghai, China – October 25, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published | Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" MagazineShanghai, China – October 22, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published |
J&K News: Terrorists Holed Up In Kathua Ahead Of Assembly Polls Phase-3 Voting , Ops OnSpeaking to reporters near the scene of the encounter, ADGP Jain said that information was received about the presence of terrorists in the area, and subsequently an operation was launched, which led..Zee News - Published | J-K: BJP suspends three leaders for indulging in 'anti-party' activities ahead of phase 3 pollingThe BJP has suspended three of its leaders after they were found involved in anti-party activities ahead of the third phase of polling in Jammu and Kashmir.DNA - Published |
Assembly Election: On Modi`s Claim Of BJP Govt In J&K, Omar Abdullah Takes `All Seats` JibeOmar has been actively campaigning with back-to-back rallies ahead of phase 3 polls in Jammu and Kashmir.Zee News - Published | J&K Phase 3 Polls: Over 12 Lakh Voters Set To Vote In Jammu On Oct 1ECI has established 1,494 polling stations across the district with 609 urban polling stations and 885 rural polling stations.Zee News - Published |
J&K Elections: Amit Shah To Address Back To Back Rallies Today Ahead Of Phase 3 Polls — Check ScheduleAhead of phase 3 polls in Jammu and Kashmir, Amit Shah will address five rallies today.Zee News - Published | Everest Medicines Announces Interim Results for First Half of 2024Shanghai, China – August 28, 2024 – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and..EQS Group - Published |
Namma Metro Phase 3: Big update on Bengaluru Metro Rail Project, Orange Line to start by...The project planned at an estimated cost of Rs 16,333 crores, is expected to greatly alleviate traffic congestion and provide a sustainable transportation alternative in one of the city's most..DNA - Published | Boost for security forces! Phase 3 of India-China border roads project started; to give impetus to road network in eastern LadakhIndia's Border Roads Organisation, in conjunction with CPWD and NPCC, has initiated Phase III of the India-China Border Roads project to bolster infrastructure in eastern Ladakh. While some key roads..IndiaTimes - Published |
New 'vaccine-like' HIV drug could cost just $40: researchersGilead's HIV drug Lenacapavir could reduce costs from $40,000 to $40, aiding high-risk groups. UNAIDS and Byanyima urge licensing via the Medicines Patent Pool. Hill's research supports affordability...IndiaTimes - Published | Everest Medicines Announces Official Acceptance Granted on NEFECON® Supplementary Application by China National Medical Products AdministrationShanghai, China – July 18^th, 2024—Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published |
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative ColitisShanghai, China – July 15^th, 2024—Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery , clinical development, manufacturing and..EQS Group - Published | Southern Peripheral Road Emerging as the Heart of Gurugram Real EstateThe Southern Peripheral Road (SPR) in Gurugram is rapidly transforming into one of the most coveted real estate destinations in the National Capital Region (NCR). Spanning 16 kilometres, SPR has become..NewsVoir - Published |
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland ChinaShanghai, China – May 14, 2024 —Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and..EQS Group - Published | 'Starwood Towers' by Navin's Conferred with CIDC Vishwakarma Award Alongside Green Initiative CertificationNavin's a leading name in the real estate sector, has been bestowed with the prestigious Vishwakarma Award for 'Achievement in Construction Health, Safety & Environment', also received the..NewsVoir - Published |
EC: 65.7% voted in Phase 3, women’s tally higher than men in 4 statesEC said a copy of Form 17C has also been provided for every polling station in a constituency to candidates through their polling agents. “Actual data of Form 17 C shall prevail which is already..IndiaTimes - Published | 65.68 per cent polling in phase 3 of Lok Sabha elections, says Election CommissionOn May 7, the third phase of Lok Sabha polling in 93 constituencies yielded a 65.68% voter turnout, as per the Election Commission. Male turnout stood at 66.89%, females at 64.41%, and third-gender..IndiaTimes - Published |
Dip again but gap narrows: 64.5% vote in phase 3, 66% in 2019Voter turnout in the third phase of polling for 93 Lok Sabha seats on Tuesday touched 64.5%, compared with 66% in 2019, as voting for more than half the constituencies for the 543-member lower House..IndiaTimes - Published | Google doodle celebrates Phase 3 of Lok Sabha elections 2024The May 7th Google Doodle commemorates the third phase of Lok Sabha Elections 2024 held on Tuesday. Instead of the traditional "Google" logo, the doodle showcases an uplifted index finger adorned with..IndiaTimes - Published |
Lok Sabha Elections Phase 3: High-Profile Seats Baramati, Gulbarga, Mainpuri Up for Grabs | 7 PointsPhase III of Lok Sabha elections sees voters from 93 seats across 10 states, with notable candidates' fates hanging on the line.Zee News - Published | Voting under way for 93 seats in phase 3 of Lok Sabha polls: What's at stakeIndiaTimes - Published |
Lok Sabha Elections 2024: 93 seats to go to polls in phase 3 today; check key candidates, electoral battlesNinety-three seats spread over 10 states and a union territory will go to polls today after high-pitched campaigning that saw political temperatures soar amid the sweltering May heat.DNA - Published | Lok Sabha Elections 2024, Phase 3: Voting in 93 seats today, check list of key constituencies hereThe 18th Lok Sabha elections will hold their third phase on May 7, following the conclusion of voting in the first two phases on April 19 and April 26.DNA - Published |